Platelets and coagulation in infection

Area of Science:

• Critical care medicine
• Hematology
• Immunology

Background:

• Disseminated intravascular coagulation (DIC) is a severe complication of sepsis, significantly increasing patient mortality and morbidity.
• DIC involves uncontrolled blood clot formation and consumption of clotting factors, leading to both thrombosis and hemorrhage.
• Current anticoagulant therapies for sepsis-associated DIC show limited efficacy, partly due to the immune system's role in initiating coagulation.

Purpose of the Study:

• To review current anticoagulant treatments for sepsis-associated DIC.
• To explore the role of inflammation, platelets, and neutrophil extracellular traps (NETs) in sepsis-induced coagulation.
• To discuss the development of future therapeutic strategies targeting these key mediators.

Main Methods:

• Literature review of current research on sepsis-associated DIC.
• Analysis of studies investigating the interplay between inflammation and coagulation.
• Examination of the role of platelets and NETs in infection-related coagulation.

Main Results:

• Sepsis-induced coagulation is complex, involving systemic inflammation.
• Platelets and NETs are identified as critical mediators in infection-driven coagulation processes.
• Existing anticoagulants have mixed outcomes, highlighting the need for novel approaches.

Conclusions:

• Effective treatment of sepsis-associated DIC requires addressing the interaction between inflammation and coagulation.
• Targeting platelet and NET-mediated coagulation pathways holds promise for future therapeutic development.
• Further research into novel anticoagulants that modulate immune responses is warranted.